CORRECTING and REPLACING Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 2, 2023

Rhea-AI Summary

Aurinia Pharmaceuticals to release third quarter financial and operational results on November 2, 2023

Positive

• Aurinia Pharmaceuticals will release financial and operational results for the third quarter of 2023 on November 2, 2023.

Negative

• None.

EDMONTON, Alberta--(BUSINESS WIRE)-- Note revised call-in number for participants 877-407-9170 / +1 201-493-6756 (Toll-free U.S. & Canada)

The updated release reads:

AURINIA PHARMACEUTICALS TO RELEASE THIRD QUARTER FINANCIAL AND OPERATIONAL RESULTS ON NOVEMBER 2, 2023

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for the third quarter of 2023, on Thursday, November 2, 2023, before markets open. Aurinia’s management team will host a conference call/webcast at 8:30 am ET that day to review these results and provide a general business update. Interested participants can dial 877-407-9170 / +1 201-493-6756 (Toll-free U.S. & Canada). The audio webcast can also be accessed under "News/Events” through the “Investors” section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available on Aurinia’s website.

About Aurinia

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations with high unmet medical needs that are impacted by autoimmune, kidney, and rare diseases. In January 2021, the Company introduced LUPKYNIS® (voclosporin), the first FDA-approved oral therapy dedicated to the treatment of adult patients with active lupus nephritis. The Company’s head office is in Edmonton, Alberta, its U.S. commercial office is in Rockville, Maryland. The Company focuses its development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231019615230/en/

Investor/Media:

ir@auriniapharma.com

Source: Aurinia Pharmaceuticals Inc.

FAQ

When will Aurinia Pharmaceuticals release its third quarter financial and operational results?

Aurinia Pharmaceuticals will release its third quarter financial and operational results on November 2, 2023.

What time will the conference call/webcast be held?

The conference call/webcast will be held at 8:30 am ET on November 2, 2023.

How can interested participants access the conference call/webcast?

Interested participants can dial 877-407-9170 / +1 201-493-6756 (Toll-free U.S. & Canada) or access the audio webcast through the "News/Events" section of the Aurinia corporate website at www.auriniapharma.com.

Will there be a replay of the webcast available?

Yes, a replay of the webcast will be available on Aurinia's website.